Day 2-psychopharmacotheapy Flashcards
psychopharmacotherapy
a subspeciality of pharmacology
classes of psychopharm
antipsychotics
mood stabilizers
antidepressants
antianxiety
stimulants
pharmacodynamics
where drugs act
what does the drug do to the body
how intense of an effect does it have
where does it have that effect
4 sites of drug action
receptors
ion channels
enzymes
carrier proteins
receptors
all drugs mimic some biological action that we naturally have
agonist
working with or add to the natural process
antagonist
working against the natural biologic process
selectivity
specific for a receptor
lock and key
affinity
degree of attraction
intrinsic activity
ability to produce a biologic response once it is attached to receptor
will it actually do waht we want and produce a therapeutic effect
ion channels
drugs can block or open then
example of ion channels
benzodiazepine drug facilitate GABA neurotransmitter in opening the chloride ion channel
enzymes
complex proteins that catalyze specific biochemical reactions within cells and are targets for some drugs
enzyme example
monoamine oxidase is an enzyme that breaks down most bioamine neurotransmitters
MAOIs inhibit the breakdown of bioamine neurotransmitters
bioamine neurotransmitters
NE, DA serotonin
too much NE
anxiety
too much DA
psychosis or depression
too much MAO
they break down serotonin causing depression
prescribing medication
we don’t know what causes mental health symptom so we try all classes until one works
carrier proteins
function is to take neurotransmitter back into presynaptic cell after neurotransmitter have activated receptors in the synapse
example of carrier protein
SSRI mostly used for anxiety, depression, schizophrenia and PTSD
efficacy
ability to produce desired response
potency
dose required to produce desired response
ss of effect due to biologic adaptation
tolerance
treatment refractory
side effects
tolerance
your body getting used to having them and this becomes its baseline
treatment refractory
drug resistant from the start so they don’t respond to anything
side effects
all meds have them because we have receptors distributed in all parts of the body but we only want to target the brain
drug toxicity
concentation of the drug in the body greater than the safe range and may become harmful or poisonous to the body
therapeutic index
ratio between minimum effective dose and maximum safe dose
the higher the ratio the better because more space between high and low
pharmacokinetics
what does the body do to a drug
ADME
absorption
movement from the site of administration to the plasma
ways to administer psychotropic medications
oral
IM
IV
IM injections
short or long acting
good for non compliance
no pocketing
convinient
first pass metabolism
before reaching the circulation
higher first pass lower response
bioavailability
how much reached the circulation unchanged
distribution
reflects how easy it is for a drug to pass out of teh systemic circulation and move into other types of tissues
solubility of drugs
most are water soluble and don’t go to the brain
psychiatric drugs must cross BBB and are therefore fat soluble
factors effecting distribution
amount of blood flow or perfusion within the tissue
how lipophilic the drug is
anatomic barriers like the BBB the drug must cross
metabolism
process by which the drug is altered and broken down into smaller substances (metabolites ) that are usually inactive
commonly carried out in the liver
lipid soluble and metabolism
usually become more water soluble and are therefore excreted
excretion
the elimination from the body eitehr unchanged or as metabolites
half life
the time required for plasma concentrations of the drug to be reduced by 50%
dosing frequency based on this
dosing
administration of medication over time so that therapeutic levels can be achieved
steady state
drug accumulates and plateuas at a particular level
rate of accumulation is determined by half life
reaching steady state
when the rate of drug input is equal to the rate of drug elimination
maintenace dosing
5x the elimination half life for a drug after regular dosing started
plateaus
any increase in dose doesn’t improve condition
titration
slowly working up to an effective dose
done because of severe side effects, allergy risk or narrow therapeutic indexi
individual variations of drug effects age
alteration in gastric absorption
renal function is altered in very young and old
liver metabolism decreases with age
ethnicity and genetic make up variability
genetics play a significant role in the metabolism of medication
phases of drug treatment
initiation
stabilization
maintenance
discontiuation
stabilization
from the start until you achieve a stable level that is working
discontinuation
not common in mental health
antipsychotic medication target symptoms
psychotic symptoms
positive and negative
types of antipsychotics
first generation/typical
second generation/atypical. Good for positive and negative
preparations of antipsychotics
Oral
IM
depot-haloperidol and fluphenazine
long acting injectable-risperdal constants
side effects antipsychotics
orthostatic hypotension
anticholinergic
metabolic syndrome/weight gain
endocrine and sexual drive decreased
blood dysstasias agranulocytosis (clozapine)
EPS
NMS
acute agitation
5mg haloperidol and 5mg benzodiazepine
poor response to antipsychotic medication
obtaining antipsychotic plasma levels in patients who hhave had poor response despite a trial with an adequate dose/duration of medication can be helpful to rule out adherence, idenntify rapid elimination, confirm true treatment resistance
rapid elimination
their half life is much shorter than normal resulting in low blood levels
typical antipsychotics
phenothiazines
haloperidol (haldol)h